Royal Bank of Canada
EXAS

Royal Bank of Canada’s Exact Sciences EXAS Stock Holding History

Royal Bank of Canada’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-82,548
Closed -$8.38M – 7280
2025
Q4 		$8.38M Sell
82,548
-15,518
-16% -$1.25M ﹤0.01% 2064
2025
Q3 		$5.37M Sell
98,066
-66,522
-40% -$3.32M ﹤0.01% 2620
2025
Q2 		$8.75M Buy
164,588
+61,302
+59% +$3.11M ﹤0.01% 2124
2025
Q1 		$4.47M Buy
103,286
+714
+0.7% +$36.2K ﹤0.01% 2340
2024
Q4 		$5.76M Sell
102,572
-61,730
-38% -$3.84M ﹤0.01% 2201
2024
Q3 		$11.2M Buy
164,302
+84,315
+105% +$4.76M ﹤0.01% 1706
2024
Q2 		$3.38M Sell
79,987
-138,793
-63% -$7.64M ﹤0.01% 2499
2024
Q1 		$15.1M Buy
218,780
+35,075
+19% +$2.22M ﹤0.01% 1414
2023
Q4 		$13.6M Buy
183,705
+13,394
+8% +$878K ﹤0.01% 1525
2023
Q3 		$11.6M Buy
170,311
+6,890
+4% +$585K ﹤0.01% 1470
2023
Q2 		$15.3M Buy
163,421
+54,104
+49% +$4.22M ﹤0.01% 1313
2023
Q1 		$7.41M Sell
109,317
-4,891
-4% -$314K ﹤0.01% 1775
2022
Q4 		$5.65M Sell
114,208
-20,465
-15% -$836K ﹤0.01% 2039
2022
Q3 		$4.38M Sell
134,673
-86,642
-39% -$3.57M ﹤0.01% 2181
2022
Q2 		$8.72M Buy
221,315
+92,282
+72% +$4.93M ﹤0.01% 1660
2022
Q1 		$9.02M Buy
129,033
+3,109
+2% +$227K ﹤0.01% 1785
2021
Q4 		$9.8M Sell
125,924
-18,720
-13% -$1.65M ﹤0.01% 1901
2021
Q3 		$13.8M Sell
144,644
-550
-0.4% -$58.1K ﹤0.01% 1600
2021
Q2 		$18M Buy
145,194
+2,796
+2% +$334K ﹤0.01% 1419
2021
Q1 		$18.8M Buy
142,398
+6,821
+5% +$934K 0.01% 1313
2020
Q4 		$18M Sell
135,577
-4,503
-3% -$545K 0.01% 1318
2020
Q3 		$14.3M Buy
140,080
+6,835
+5% +$590K 0.01% 1303
2020
Q2 		$11.6M Sell
133,245
-10,912
-8% -$872K ﹤0.01% 1372
2020
Q1 		$8.36M Buy
144,157
+947
+0.7% +$76.9K ﹤0.01% 1472
2019
Q4 		$13.2M Buy
143,210
+33,009
+30% +$2.9M ﹤0.01% 1429
2019
Q3 		$9.96M Buy
110,201
+7,070
+7% +$806K ﹤0.01% 1576
2019
Q2 		$12.2M Sell
103,131
-886
-0.9% -$89.3K ﹤0.01% 1430
2019
Q1 		$9.01M Buy
104,017
+28,113
+37% +$2.39M ﹤0.01% 1590
2018
Q4 		$4.79M Buy
75,904
+24,837
+49% +$1.7M ﹤0.01% 2015
2018
Q3 		$4.03M Buy
51,067
+7,735
+18% +$504K ﹤0.01% 2271
2018
Q2 		$2.59M Sell
43,332
-126,231
-74% -$6.79M ﹤0.01% 2529
2018
Q1 		$6.84M Buy
169,563
+126,879
+297% +$6.19M ﹤0.01% 1776
2017
Q4 		$2.24M Sell
42,684
-201,138
-82% -$10.7M ﹤0.01% 2640
2017
Q3 		$11.5M Buy
243,822
+12,118
+5% +$488K 0.01% 1438
2017
Q2 		$8.2M Buy
231,704
+196,703
+562% +$6.07M ﹤0.01% 1633
2017
Q1 		$827K Buy
35,001
+4,884
+16% +$96.8K ﹤0.01% 3222
2016
Q4 		$402K Sell
30,117
-3,918
-12% -$63.3K ﹤0.01% 3935
2016
Q3 		$633K Buy
34,035
+4,625
+16% +$81.5K ﹤0.01% 3516
2016
Q2 		$360K Buy
29,410
+8,076
+38% +$60.8K ﹤0.01% 3969
2016
Q1 		$144K Sell
21,334
-41,372
-66% -$265K ﹤0.01% 4571
2015
Q4 		$578K Buy
62,706
+23,318
+59% +$217K ﹤0.01% 3632
2015
Q3 		$708K Buy
39,388
+23,323
+145% +$536K ﹤0.01% 3168
2015
Q2 		$478K Sell
16,065
-15,750
-50% -$396K ﹤0.01% 3639
2015
Q1 		$701K Sell
31,815
-12,920
-29% -$328K ﹤0.01% 3188
2014
Q4 		$1.23M Buy
44,735
+31,645
+242% +$770K ﹤0.01% 2743
2014
Q3 		$254K Buy
13,090
+2,800
+27% +$51.3K ﹤0.01% 4022
2014
Q2 		$175K Buy
10,290
+850
+9% +$11.7K ﹤0.01% 4254
2014
Q1 		$134K Buy
9,440
+2,190
+30% +$29.6K ﹤0.01% 4380
2013
Q4 		$85K Sell
7,250
-11,387
-61% -$131K ﹤0.01% 4667
2013
Q3 		$220K Buy
18,637
+11,952
+179% +$153K ﹤0.01% 4024
2013
Q2 		$93K Buy
+6,685
New +$72.6K ﹤0.01% 4346

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Royal Bank of Canada's EXAS Position: Q1 2026 in Review

Royal Bank of Canada sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 82,548 shares — an estimated $8.38M sold.

Royal Bank of Canada first reported a position in EXAS in Q2 2013 and held it in 51 quarters. The position peaked at $18.8M in Q1 2021. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Royal Bank of Canada reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Royal Bank of Canada sold 82,548 Exact Sciences shares in Q1 2026, an estimated $8.38M.
  • Royal Bank of Canada first reported a position in Exact Sciences in Q2 2013 and held it in 51 quarters.
  • Royal Bank of Canada's Exact Sciences position peaked at $18.8M in Q1 2021.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.